Compound Summary
Compound Name: | Pyridine-2,4-dicarboxylic acid |
Compound CID: | 10365 |
Synonyms: | Pyridine-2,4-dicarboxylic acid 499-80-9 2,4-PYRIDINEDICARBOXYLIC ACID Lutidinic acid 2,4-Lutidinic acid More... |
Iupac Name: | pyridine-2,4-dicarboxylic acid |
InChI: | InChI=1S/C7H5NO4/c9-6(10)4-1-2-8-5(3-4)7(11)12/h1-3H,(H,9,10)(H,11,12) |
InChIKey: | MJIVRKPEXXHNJT-UHFFFAOYSA-N |
Canonical Smiles: | C1=CN=C(C=C1C(=O)O)C(=O)O |
Isomeric Smiles: | C1=CN=C(C=C1C(=O)O)C(=O)O |
Molecular Weight: | 167.12 |
Molecular Formula: | C7H5NO4 |
Molecular Weight: | 167.12 |
Molecular Formula: | C7H5NO4 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 12 |
Complexity: | 204 |
Pyridine-2,4-dicarboxylic acid | Pyridine-2,4-dicarboxylic acid |
---|---|
Pyridine-2,4-dicarboxylic acid |
499-80-9 |
2,4-PYRIDINEDICARBOXYLIC ACID |
Lutidinic acid |
2,4-Lutidinic acid |
2,4-PDCA |
UNII-AFI29F0TVL |
AFI29F0TVL |
CHEBI:44737 |
EC 207-892-2 |
MFCD00149413 |
108882-06-0 |
4nrq |
PD2 |
EINECS 207-892-2 |
NSC 403248 |
2,4-Dicarboxypyridine |
4-carboxypicolinic acid |
2vd7 |
2w2i |
4ie0 |
pyridine carboxylate, 6a |
ACMC-1BNB9 |
2,4-Pyridine-dicarboxylate |
SCHEMBL72377 |
cid_10365 |
MLS000078055 |
CHEMBL316034 |
GTPL8744 |
2,4-Pyridine Dicarboxylic Acid |
DTXSID9060104 |
2, 4-PDCA |
BDBM26113 |
HMS2433N17 |
ZINC391915 |
2,4-PyridinedicarboxylicAcidHydrate |
AMY33339 |
MFCD00006296 |
NSC403248 |
SBB071492 |
AKOS015892026 |
GS-6110 |
MCULE-5012604214 |
NSC-403248 |
SB40766 |
compound 6a PMID: 18942826 |
NCGC00020450-01 |
NCGC00020450-02 |
NCGC00020450-03 |
AC-13532 |
SMR000036938 |
ST096003 |
SY013848 |
2,4-Pyridinedicarboxylic acid, >=98.0% |
DB-013329 |
FT-0628051 |
P0553 |
P2416 |
S5906 |
Z6086 |
2,4-Pyridinedicarboxylicacid, hydrate (1:1) |
EN300-82359 |
A16372 |
BRD-K36162096-001-03-0 |
BRD-K36162096-001-04-8 |
BRD-K36162096-002-01-2 |
Q27076768 |
F8889-3784 |
Z1696869962 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 10.000000000000000 | mM | 15.500000000000000 | 18.100000000000000 | 0.170000000000000 | S | N2 | 26729005 | Active | ||||
Caenorhabditis elegans | 10.000000000000000 | mM | 18.100000000000000 | 15.000000000000000 | -0.170000000000000 | S | N2 | 26729005 | Inactive | ||||
Caenorhabditis elegans | 5.000000000000000 | mM | 18.100000000000000 | 17.700000000000000 | -0.020000000000000 | NS | N2 | 26729005 | Inactive | ||||
Caenorhabditis elegans | 5.000000000000000 | mM | 15.500000000000000 | 19.200000000000000 | 0.240000000000000 | S | N2 | 26729005 | Active | ||||
Caenorhabditis elegans | 5.000000000000000 | mM | 16.000000000000000 | 17.700000000000000 | 0.110000000000000 | S | N2 | 26729005 | Active | ||||
Caenorhabditis elegans | 10.000000000000000 | mM | 16.000000000000000 | 17.800000000000000 | 0.110000000000000 | NS | N2 | 26729005 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 0.240000000000000 | 1 | 6 |